InvestorsHub Logo
Followers 14
Posts 433
Boards Moderated 0
Alias Born 09/14/2013

Re: Couch post# 268028

Thursday, 08/03/2017 7:01:11 AM

Thursday, August 03, 2017 7:01:11 AM

Post# of 399340
My prediction is the FDA will say
benefits outweigh risks for SequestOx
FDA will approve SequestOx!

Catalysts for significant revenue growth and improvement of share price in the very near future!

1. SequestOxTM (ELI-200) Opioid
NDA Pending Approval
Benefits outweigh risks

http://m.ir.elitepharma.com/profiles/investor/ResLibraryView.asp?ResLibraryID=83707&GoTopage=1&Category=2163&BzID=2258&t=1948&G=939

2. Oxycodone Hydrochloride ER with ADT
10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60 mg and 80 mg Tablets
(Generic OxyContin ADT)
Pending ANDA submittal
Submittal this quarter
Positive, top line BE results press released on 1/17/17

http://m.ir.elitepharma.com/profiles/investor/ResLibraryView.asp?ResLibraryID=82907&GoTopage=2&Category=2163&BzID=2258&t=1948&G=939

3. Oxycodone Hydrochloride and Acetaminophen
USP 5 mg/325 mg, 7.5 mg/325 mg, 10 mg/325 mg Tablets
(Generic Percocet)
Pending approval
ANDA submitted on 8/10/2016

http://m.ir.elitepharma.com/profiles/investor/ResLibraryView.asp?ResLibraryID=82211&GoTopage=3&Category=2163&BzID=2258&t=1948&G=939

4. Hydrocodone Bitartrate and Acetaminophen, USP 5 mg/325 mg, 7.5 mg/325 mg and 10 mg/325 mg Tablets
(Generic Norco)
Pending approval
ANDA submitted on 12/12/2016

http://m.ir.elitepharma.com/profiles/investor/ResLibraryView.asp?ResLibraryID=82799&GoTopage=2&Category=2163&BzID=2258&t=1948&G=939

5. Synthetic Narcotic Analgesic
(Undisclosed Generic)
Pending approval
ANDA submitted on 4/4/2017

http://m.ir.elitepharma.com/profiles/investor/ResLibraryView.asp?ResLibraryID=83245&GoTopage=1&Category=2163&BzID=2258&t=1948&G=939

6. Undisclosed Generic
(Undisclosed Generic)
Positive, top line BE results press released on 5/30/17
Pending Approval
ANDA submitted on?

http://m.ir.elitepharma.com/profiles/investor/ResLibraryView.asp?ResLibraryID=83551&GoTopage=1&Category=2163&BzID=2258&t=1948&G=939

7. Additional Approved ANDAs
*pending site transfer

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News